Received: from netlink.com.au (merlin.netlink.com.au [203.16.172.196]) by csf.Colorado.EDU (8.8.5/8.8.4/CNS-4.1p-nh) with ESMTP id JAA29434 for ; Sun, 22 Nov 1998 09:07:47 -0700 (MST) Received: from netlink.com.au (h033.mel.netlink.com.au [203.62.225.33]) by netlink.com.au (8.8.8/8.8.8) with ESMTP id DAA05161 for ; Mon, 23 Nov 1998 03:06:04 +1100 Message-ID: <3658366E.3F6CD9C9@netlink.com.au> Date: Mon, 23 Nov 1998 03:06:06 +1100 From: rc&am Reply-To: rcollins@netlink.com.au X-Mailer: Mozilla 4.04 [en] (Win95; I) MIME-Version: 1.0 To: PROGRESSIVE POPULATION NETWORK Subject: more on quinacrine Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit Quinacrine Sterilization: An Unsafe Method of Female Sterilization? -------------------------------------------------------------------------------- Quinacrine sterilization is a non-surgical method of female sterilization that was invented in Chile by Jamie Zipper in the early 1970's. The procedure involves inserting a quinacrine pellet into a woman's uterus where it "inflicts injury- something similar to a chemical burn- that causes scar tissue to form. The scar tissue in turn blocks reproductive processes."[1] Although the method has been used by doctors (especially in developing and third world countries) for over thirty years, questions about its safety and its effectiveness remain unanswered. Quinacrine is used for sterilization purposes today despite the fact that it has not been adequately tested. If a non-surgical method could be deemed both safe and effective it could become a very important part of women's health care world wide, especially in places where surgical forms of sterilization are necessary but unsafe. Unfortunately the quinacrine method does not yet fill this void in female reproductive methods. Toxicology Studies were not done on quinacrine until thirty years after it was introduced as an anti malarial drug. Toxicology studies are a major step in drug testing, a step required by most of the world's drug administrations. The Federations of Gynecology and Obstetrics states that "no experimental method should be tested in humans before adequate toxicology studies [are done] in animals to clarify questions of safety."[2] Studies done by the WHO toxicology panel in 1991 found that "the evidence concerning mutagenicity was inconclusive" and that "further toxicological studies... were required."[3] There were additional questions raised by the WHO toxicology panel with regards to the fact that quinacrine is often given with ibuprofen, ampicillin or ergotamine. They noted that there is no scientific evidence to support using these drugs in conjunction with quinacrine and that toxicology studies should be done on all the drugs to see how they interact together. Another set of toxicology studies was done in 1995 by Family Health International (FHI). FHI discovered that three of the four studies showed mutagenicity, which can indicate that something is carcinogenic or cancer causing. Although not everything that is mutagenetic is carcinogenic, the results of these tests indicate that more direct carcinogenic studies need to be done in order to discover how safe quinacrine is. To date, these studies have not been done; the quinacrine sterilization method continues to be used. Beyond the testing, little is known about the actual physical affects that this procedure can have on women. Quinacrine, in high doses, has been known to cause toxic psychosis (a form of chemical insanity), as well as nervousness, hallucinations and psychotic episodes. The fact that these reactions are known to come from high doses of quinacrine make finding an accurate dosage imperitive. Some women, after having had the procedure, have reported "unexplained bleeding, a sensation of burning internally and pain after insertion." [4] Data collection on this procedure is difficult; this process of sterilization is not legal or medically accepted so there are few records. Data on pregnancy after the insertion of the quinacrine pellet has been kept more accurately. In Chile the rate of pregnancy in women under thirty five was 8.7 percent after five years and 11.7 percent after ten years. The rate of pregnancy for women over thirty five is slightly lower, probably due to the fact that fertility decreases after the age of thirty five. The rate of pregnancy is absurdly high for a method that is professes to sterilize women. Dr. Lisa Rarick, Medical Officer at the USFDA thinks that "the failure rate [of quinacrine sterilizations should not] be too far off that for surgical sterilization, especially since it is sterilization - not a form of contraception that is being offered... five percent would be too high."[5] If five percent is considered too high to be considered "effective" then quinacrine should not be used as a method of sterilization. People have raised concerns over a possible rise in the rate of ectopic pregnancies in women who become pregnant after being "sterilized" by the quinacrine method. Any rise in ectopic pregnancies must be carefully considered because ectopic pregnancies are very dangerous to the mother. In addition, the effects that the quinacrine method has on pregnancies that do occur has not yet been studied even though the method inherently damages the female reproductive organs. The last concern raised about quinacrine is the fact that women may be participating in this method of sterilization without knowing that it is still "experimental" and that they are a part of a clinical test group. There is concern that some of the women are being sterlized with quinacrine without full knowledge of the possible risks. Reports from an independent nurse practitioner in Pakistan is that "patients are recruited... and given little information or time to fully understand and think about the implications of this type of procedure."[6] This attitude seems to be prevalent elsewhere as well. In promotion of quinacrine, a drug without adequate testing, some supporters seem to "use the fact that women's lives in developing countries are more at risk for pregnancy to justify why a sterilization method need not be a safe or effective for them as for women in developed countries"[7] This attitude encourages the continued used of quinacrine among women as a viable method in developing and third world countries despite the fact that there are huge risks involved for these women. If a non-surgical method of female sterilization could be discovered, tested properly and determined to be safe and effective, the benefits would be huge. As of now, quinacrine is not that drug and the quinacrine method is not the answer. Mistakes have been made in the past regarding inadequate drug testing before drugs are used on a widespread scale. DES, breast implants, and other poorly tested drugs and medical procedures have cost women their fertility, their health and their lives. Drugs need to be tested properly. Time , money and resources are all things that can be worked around if a product is needed. There is no excuse for risking lives, health and fertility simply for the convenience of putting a drug out which has not been properly tested. It is too late to repair the damage that has already been done with quinacrine, but it is not too late to continue with the necessary testing and go forward from here. -------------------------------------------------------------------------------- Notes 1 Taken from BAOBAB Press, Vol.3, Num. 23 (http:www.//africa2000com/BNDX) 2 Berer, Marge; The quinacrine Controversy One Year ON, p.105, Reproductive Health Matters, No.4, November 1994 3 ibid. 2 p101 4 Berer, Marge; The Quinacrine Controversy Continues, p.144, Reproductive Health Matters, No.6, November 1995 5 ibid 2. p.102 6 ibid 2, p104 7 ibid 2, p.100 --------------------------------------------------------------------------------